Ocugen (OCGN) FCF Margin (2014 - 2026)
Ocugen's (OCGN) quarterly FCF Margin came in at 1422.05% in Q1 2026, down 11395.0% YoY from N/an in Q1 2025, and down 119.43% on a QoQ basis from 7319.69% in Q4 2025.
Powered by 
Analysis
Ocugen (OCGN) FCF Margin (2014 - 2026) Analysis & Trends
Ocugen (OCGN) has 7 years of FCF Margin data on file, last reported at 1422.05% in Q1 2026.
- Quarterly FCF Margin fell 11395.0% year-over-year to 1422.05% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1334.29% (down 18539.0% YoY) and the FY2025 annual result came in at 1295.01%, down 17228.0% from the prior year.
- FCF Margin slipped to 1422.05% in Q1 2026, from 7319.69% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 7319.69% in Q4 2025 to a low of 4481.26% in Q1 2023.
- A 5-year average of 1252.87% and a median of 1308.1% in 2025 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2023 — FCF Margin plunged 173070 bps — and 2025, when it surged 867794 bps.
- Tracing OCGN's FCF Margin over 5 years: stood at 1887.83% in 2022, then surged by 78 bps to 407.17% in 2023, then plunged by 234 bps to 1358.25% in 2024, then soared by 639 bps to 7319.69% in 2025, then slumped by 119 bps to 1422.05% in 2026.
- The last three FCF Margin figures came in at 1422.05% (Q1 2026), 7319.69% (Q4 2025), and 734.93% (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -388.28% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 25.68% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 22.62% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 70.82% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -22.35% |
| 10 | Ocugen | 458.91 Mn | 358.81 Mn | - | -821.17% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -821.17% |
| Mar 31, 2026 | -1,422.05% |
| Dec 31, 2025 | 7,251.81% |
| Sep 30, 2025 | -742.41% |
| Jun 30, 2025 | -784.63% |
| Mar 31, 2025 | -1,308.10% |
| Dec 31, 2024 | -1,358.25% |
| Sep 30, 2024 | -1,036.88% |
| Jun 30, 2024 | -913.58% |
| Mar 31, 2024 | -1,276.82% |
| Dec 31, 2023 | -995.32% |
| Sep 30, 2023 | -461.50% |
| Jun 30, 2023 | -4,450.10% |
| Mar 31, 2023 | -4,481.26% |
| Dec 31, 2022 | -2,154.49% |
| Sep 30, 2022 | -3,250.21% |
| Jun 30, 2022 | -2,297.82% |
| Mar 31, 2022 | -3,135.40% |
| Jun 30, 2020 | -7,134.88% |
| Sep 30, 2014 | -0.42% |